Praram 9 Hospital PCL
Praram 9 Hospital PCL operates in the healthcare facilities and services industry, generating revenue primarily through hospital services and pharmaceuticals.
Business. Praram 9 Hospital PCL (PR9.BK) is a healthcare facilities and services company headquartered in Thailand. The firm operates within the Healthcare Services & Equipment sector, providing medical services and pharmaceutical-related activities. It is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue mix are not disclosed.
Analyst recommendations
9 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Praram 9 Hospital PCL (PR9.BK) is a healthcare facilities and services company headquartered in Thailand. The firm operates within the Healthcare Services & Equipment sector, providing medical services and pharmaceutical-related activities. It is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue mix are not disclosed.
Praram 9 Hospital PCL maintains a strong liquidity position, with a current ratio of 3.71 and cash and equivalents amounting to 962.05 million THB, indicating a solid ability to meet short-term obligations. The company's price-to-book ratio of 2.54 and a price-to-tangible-book ratio of 2.54 suggest that the market values the company at a premium relative to its book value.
In terms of profitability, the company's return on equity (ROE) of 2.71% and return on assets (ROA) of 2.34% are below the industry's preferred metrics, indicating that the company is not generating returns as efficiently as its peers. The operating income of 160.38 million THB and net income of 139.10 million THB reflect a moderate level of profitability, but the high price-to-earnings ratio of 93.84 suggests that the market is paying a premium for these earnings.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which may expose it to higher concentration risk. The company's free cash flow is negative at -52.33 million THB, indicating that it is not generating sufficient cash from operations to cover its capital expenditures of -107.55 million THB.
Looking ahead, the company is expected to see a growth in revenue, with a positive outlook for the current fiscal year. The mean price target of 23.97 THB and median price target of 23.00 THB suggest that analysts have a positive outlook on the company's future performance. The company's liquidity risk is low, and there are no immediate filing-based liquidity or dilution flags, indicating a stable financial position.
Recent events and filings do not indicate any significant changes in the company's operations or financial status. The company's capital structure is characterized by a low debt-to-equity ratio of 0.0, suggesting that it is primarily financed through equity. The company's market cap of 13.05 billion THB and a market price of 16.6 THB per share indicate a relatively high valuation in the market.
- Praram 9 Hospital PCL has a strong liquidity position with a current ratio of 3.71 and significant cash reserves.
- The company's profitability metrics, such as ROE and ROA, are below industry standards, indicating inefficiencies in generating returns.
- The company's revenue is concentrated in a single segment, which may increase its exposure to market risks.
- Analysts have a positive outlook on the company, with a mean price target of 23.97 THB and a median price target of 23.00 THB.
- The company's capital structure is primarily equity-based, with a low debt-to-equity ratio of 0.0.
- "margin_outlook_rationale": "The company's operating margin is expected to remain stable due to consistent revenue and controlled operating expenses.",
Bull / Bear case
Generated · model-assistedRevenue grew 15.2% CAGR over four years, demonstrating strong top-line expansion momentum for the hospital.
Net income surged 34.8% CAGR over four years, significantly outpacing revenue growth and indicating operating leverage.
Analysts project 48.9% upside to a mean price target of 23.97 THB, signaling strong market confidence.
Return on equity of 2.7% falls below the healthcare cohort median of 4.6%, indicating inefficient capital utilization.
Long-term debt increased to 15.98 million THB in FY2026, nearly tripling from the prior year's level.
In focus — financials by report
Revenue THB 1.29B, +3,7% YoY; Operating income −6,9% YoY.
- ▍Revenue THB 1.29B, +3,7% YoY
- ▍Operating income −6,9% YoY
- ▍Net income −8,0% YoY
- ▍Free cash flow +11,0% YoY
- ▍Net margin 14.3%
Revenue THB 1.40B, +11,3% YoY; Operating income +17,7% YoY.
- ▍Revenue THB 1.40B, +11,3% YoY
- ▍Operating income +17,7% YoY
- ▍Net income +5,0% YoY
- ▍Free cash flow −214,9% YoY
- ▍Net margin 15.5%
Revenue THB 1.37B, +11,3% YoY; Operating income +2,2% YoY.
- ▍Revenue THB 1.37B, +11,3% YoY
- ▍Operating income +2,2% YoY
- ▍Net income +7,4% YoY
- ▍Free cash flow −9,3% YoY
- ▍Net margin 16.3%
Revenue THB 1.28B, +17,8% YoY; Operating income +34,8% YoY.
- ▍Revenue THB 1.28B, +17,8% YoY
- ▍Operating income +34,8% YoY
- ▍Net income +30,8% YoY
- ▍Free cash flow +60,4% YoY
- ▍Net margin 14.2%
Revenue THB 1.24B; Operating income THB 239.1M.
- ▍Revenue THB 1.24B
- ▍Operating income THB 239.1M
- ▍Net margin 16.1%
Revenue THB 1.26B; Operating income THB 219.7M.
- ▍Revenue THB 1.26B
- ▍Operating income THB 219.7M
- ▍Net margin 16.4%
Revenue THB 1.23B; Operating income THB 243.6M.
- ▍Revenue THB 1.23B
- ▍Operating income THB 243.6M
- ▍Net margin 16.9%
Revenue THB 1.09B; Operating income THB 160.4M.
- ▍Revenue THB 1.09B
- ▍Operating income THB 160.4M
- ▍Net margin 12.8%
Revenue THB 5.29B, +13,8% YoY; Operating income +19,2% YoY.
- ▍Revenue THB 5.29B, +13,8% YoY
- ▍Operating income +19,2% YoY
- ▍Net income +15,4% YoY
- ▍Free cash flow −40,2% YoY
- ▍Net margin 15.5%
Revenue THB 4.65B, +10,3% YoY; Operating income +22,6% YoY.
- ▍Revenue THB 4.65B, +10,3% YoY
- ▍Operating income +22,6% YoY
- ▍Net income +27,8% YoY
- ▍Free cash flow +33,3% YoY
- ▍Net margin 15.3%
Revenue THB 4.22B, +2,3% YoY; Operating income −4,7% YoY.
- ▍Revenue THB 4.22B, +2,3% YoY
- ▍Operating income −4,7% YoY
- ▍Net income −1,7% YoY
- ▍Free cash flow −47,5% YoY
- ▍Net margin 13.2%
Revenue THB 4.12B, +37,4% YoY; Operating income +133,3% YoY.
- ▍Revenue THB 4.12B, +37,4% YoY
- ▍Operating income +133,3% YoY
- ▍Net income +127,8% YoY
- ▍Free cash flow +188,5% YoY
- ▍Net margin 13.8%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1,09 |
| Revenue | —no estimate | —no estimate | 5,5B THB |
| Operating income | —no estimate | —no estimate | 999,5M THB |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Praram 9 Hospital PCL Market data — financials · 2026-05-29
- Praram 9 Hospital PCL Market data — analyst estimates · 2026-05-29
- Praram 9 Hospital PCL Market data — ESG · 2026-05-29